Leukaemia blasts (pre-BCR+ ALL) can thus hijack the pre-BCR signalling pathway to induce differentiation arrest and avoid clonal extinction, and reactivating this pathway may be an attractive therapeutic target (as reviewed in Ref. Here, BCR is linked to acute lymphoblastic leukemia.